Hetrombopag for Low/Intermediate-1 Risk MDS With Thrombocytopenia
Clinical trial NCT05024877 · UNKNOWN
Trial details
- NCT number
- NCT05024877
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2023-10-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.